Table 1. |
Signs and Symptoms of Bone Disease in Children with CKD |
Table 2. |
Frequency of Measurement of PTH, Calcium, Phosphorus, Total CO2, and Alkaline Phosphatase by Stage of CKD |
Table 3. |
Target Range of Serum PTH by Stage of CKD |
Table 4. |
Histological Features of High-Turnover Renal Osteodystrophy |
Table 5. |
Histological Features of Low-Turnover Renal Osteodystrophy |
Table 6. |
Representative Normal Values for Serum Phosphorus, Total Calcium, Blood Ionized Calcium, and Alkaline Phosphatase Concentrations |
Table 7. |
Dietary Reference Intakes of Phosphorus in Children |
Table 8. |
Steps to Calculate the Initial Binder Prescription |
Table 9. |
Phosphorus-Binding Compounds |
Table 10. |
Recommendations for Calcium Intake |
Table 11. |
Calcium Content of Common Calcium-Based Binders |
Table 12. |
Low-Phosphorus, High-Calcium Foods |
Table 13. |
Partial List of Calcium-Containing Supplements |
Table 14. |
Determining Calcium Requirements in Adults Aged 19-30 Years |
Table 15. |
Recommended Supplementation for Vitamin D Deficiency/Insufficiency in Patients with CKD Stages 3-4 |
Table 16. |
Serum Levels of PTH, Calcium, and Phosphate Required for Initiation of Oral Vitamin D Sterol Therapy, and Recommended Initial Doses in Patients with CKD Stages 2-4 |
Table 17. |
Initial Calcitriol Dosing Recommendations for Children on Maintenance Dialysis |
Table 18. |
Aluminum-Related Disorders: Features, Causes, and Considerations for Therapy |
Table 19. |
Frequency for Measurement of Serum Levels of Total CO2 |
Table 20. |
Frequency of Measurement of Calcium, Phosphorus, PTH, and Total CO2 after Kidney Transplantation |